154 related articles for article (PubMed ID: 15203864)
41. The association of MDR1 C3435T and G2677T/A polymorphisms with plasma platelet-activating factor levels and coronary artery disease risk in Turkish population.
Ayaz G; Batar B; Kanigur G; Guven M; Onaran I; Karadag B; Ilerigelen B; Dirican A; Ulutin T
Gene; 2013 Sep; 527(1):301-5. PubMed ID: 23816407
[TBL] [Abstract][Full Text] [Related]
42. Effects of MDR1 (C3435T) Polymorphism on Resistance, Uptake, and Efflux to Antiepileptic Drugs.
Shen XM; Cheng J
DNA Cell Biol; 2019 Mar; 38(3):250-255. PubMed ID: 30632789
[TBL] [Abstract][Full Text] [Related]
43. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis.
Annese V; Valvano MR; Palmieri O; Latiano A; Bossa F; Andriulli A
World J Gastroenterol; 2006 Jun; 12(23):3636-44. PubMed ID: 16773678
[TBL] [Abstract][Full Text] [Related]
44. P-glycoprotein: from genomics to mechanism.
Ambudkar SV; Kimchi-Sarfaty C; Sauna ZE; Gottesman MM
Oncogene; 2003 Oct; 22(47):7468-85. PubMed ID: 14576852
[TBL] [Abstract][Full Text] [Related]
45. Clinical aspects of the MDR1 (ABCB1) gene polymorphism.
Eichelbaum M; Fromm MF; Schwab M
Ther Drug Monit; 2004 Apr; 26(2):180-5. PubMed ID: 15228162
[TBL] [Abstract][Full Text] [Related]
46. [The effect of MDR1 gene polymorphism in the pathogenesis and the treatment of drug-resistant epilepsy].
Białecka M; Hnatyszyn G; Bielicka-Cymerman J; Droździk M
Neurol Neurochir Pol; 2005; 39(6):476-81. PubMed ID: 16355305
[TBL] [Abstract][Full Text] [Related]
47. [MDR1 genotypes related to pharmacokinetics and MDR1 expression].
Nakamura T
Yakugaku Zasshi; 2003 Sep; 123(9):773-9. PubMed ID: 14513768
[TBL] [Abstract][Full Text] [Related]
48. Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1).
Pauli-Magnus C; Kroetz DL
Pharm Res; 2004 Jun; 21(6):904-13. PubMed ID: 15212152
[TBL] [Abstract][Full Text] [Related]
49. Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.
Wolking S; Schaeffeler E; Lerche H; Schwab M; Nies AT
Clin Pharmacokinet; 2015 Jul; 54(7):709-35. PubMed ID: 25860377
[TBL] [Abstract][Full Text] [Related]
50. Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression.
Chowbay B; Li H; David M; Cheung YB; Lee EJ
Br J Clin Pharmacol; 2005 Aug; 60(2):159-71. PubMed ID: 16042669
[TBL] [Abstract][Full Text] [Related]
51. Effect of MDR1 haplotype on risk of Parkinson disease.
Tan EK; Chan DK; Ng PW; Woo J; Teo YY; Tang K; Wong LP; Chong SS; Tan C; Shen H; Zhao Y; Lee CG
Arch Neurol; 2005 Mar; 62(3):460-4. PubMed ID: 15767512
[TBL] [Abstract][Full Text] [Related]
52. ABCB1 (MDR1) rs1045642 is associated with increased overall survival in plasma cell myeloma.
Drain S; Catherwood MA; Orr N; Galligan L; Rea IM; Hodkinson C; Drake MB; Kettle PJ; Morris TC; Alexander HD
Leuk Lymphoma; 2009 Apr; 50(4):566-70. PubMed ID: 19373654
[TBL] [Abstract][Full Text] [Related]
53. The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans.
Fromm MF
Adv Drug Deliv Rev; 2002 Nov; 54(10):1295-310. PubMed ID: 12406646
[TBL] [Abstract][Full Text] [Related]
54. Genomics and the mechanism of P-glycoprotein (ABCB1).
Sauna ZE; Kim IW; Ambudkar SV
J Bioenerg Biomembr; 2007 Dec; 39(5-6):481-7. PubMed ID: 18058211
[TBL] [Abstract][Full Text] [Related]
55. Function-altering SNPs in the human multidrug transporter gene ABCB1 identified using a Saccharomyces-based assay.
Jeong H; Herskowitz I; Kroetz DL; Rine J
PLoS Genet; 2007 Mar; 3(3):e39. PubMed ID: 17352537
[TBL] [Abstract][Full Text] [Related]
56. P-glycoprotein multidrug transporter in inflammatory bowel diseases: More questions than answers.
Cario E
World J Gastroenterol; 2017 Mar; 23(9):1513-1520. PubMed ID: 28321153
[TBL] [Abstract][Full Text] [Related]
57. Pharmacogenetics of drug transporters and its impact on the pharmacotherapy.
Sakaeda T; Nakamura T; Okumura K
Curr Top Med Chem; 2004; 4(13):1385-98. PubMed ID: 15379652
[TBL] [Abstract][Full Text] [Related]
58. In silico analysis of nsSNPs in ABCB1 gene affecting breast cancer associated protein P-glycoprotein (P-gp).
Chakraborty R; Gupta H; Rahman R; Hasija Y
Comput Biol Chem; 2018 Dec; 77():430-441. PubMed ID: 30181081
[TBL] [Abstract][Full Text] [Related]
59. How to make P-glycoprotein (ABCB1, MDR1) harbor mutations and measure its expression and activity in cell cultures?
Zubiaur P; Saiz-Rodríguez M; Koller D; Ovejero-Benito MC; Wojnicz A; Abad-Santos F
Pharmacogenomics; 2018 Nov; 19(16):1285-1297. PubMed ID: 30334473
[TBL] [Abstract][Full Text] [Related]
60. The MDR1 (ABCB1) gene polymorphism and its clinical implications.
Ieiri I; Takane H; Otsubo K
Clin Pharmacokinet; 2004; 43(9):553-76. PubMed ID: 15217301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
